CION Ameerpet
Immunotherapy · Understanding Immunotherapy & the Decision
Will I Lose My Hair on Immunotherapy — What Actually Happens to Hair and Skin
No — on its own, checkpoint inhibitor immunotherapy does not commonly cause the diffuse hair loss chemotherapy is known for. If your treatment plan combines immunotherapy with chemotherapy, hair loss usually comes from the chemotherapy. Some immune-related skin and hair changes can still occur, and are worth knowing about before you start.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Not the chemo experience — Checkpoint inhibitor immunotherapy alone rarely causes the diffuse hair loss that chemotherapy drugs cause.
- Combination changes the picture — If immunotherapy is paired with chemotherapy for your cancer, hair loss is typically from the chemotherapy, not the immunotherapy.
- Other visible changes are possible — Skin rash, itching, and rare patchy hair loss resembling alopecia areata have been reported with checkpoint inhibitors.
- Still a decision for your oncology team — Whether immunotherapy is even an option depends on your cancer type and biomarkers; most patients are not candidates.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
Does Immunotherapy Cause Hair Loss?
Usually, no. Chemotherapy causes hair loss because it targets rapidly dividing cells throughout the body, and hair follicle cells divide quickly — that mechanism is what damages them. Checkpoint inhibitor immunotherapy works differently: it helps the immune system recognise and act against cancer cells rather than attacking fast-dividing cells generally, so it does not typically cause the same diffuse hair loss. Most patients on immunotherapy alone keep their hair through treatment.
This page assumes immunotherapy is already part of your treatment plan. Most cancer patients are not candidates for immunotherapy at all — eligibility depends on your cancer type and biomarker results, and is confirmed by your oncology team before any treatment decision, hair loss included.
The nuance that matters
What About Combination Treatment — Immunotherapy Plus Chemotherapy?
If your plan combines immunotherapy with chemotherapy, hair loss is a real possibility — but it comes from the chemotherapy, not the immunotherapy. Combining the two is common for several cancers, including certain lung, breast and head-and-neck cancers, because they work through different mechanisms and can be more effective given together. If chemotherapy is part of your specific regimen, expect the same hair-loss pattern chemotherapy usually causes on its own.
Once a chemotherapy course ends, immunotherapy is sometimes continued alone as maintenance treatment. At that point, most patients see hair begin to regrow, following broadly the same timeline seen after chemotherapy is stopped for any reason.
Did you know?
Some patients on checkpoint inhibitor immunotherapy for melanoma develop small, painless, vitiligo-like patches of skin that lose pigment. It looks alarming the first time you notice it, but it is a recognised immune-related skin change, not a new illness — and it should still be reported to your care team.
Side by side
Hair and Skin Effects: Chemotherapy vs Immunotherapy
A general comparison — your own experience depends on the specific drugs in your regimen, not on this table alone.
| Aspect | Chemotherapy | Immunotherapy (checkpoint inhibitor) |
|---|---|---|
| Underlying cause | Damages rapidly dividing cells throughout the body, hair follicles included | Activates the immune system against cancer cells; does not target fast-dividing cells generally |
| Typical hair pattern | Diffuse thinning or loss across the scalp, sometimes eyebrows and eyelashes too | Usually none; rare patchy loss resembling alopecia areata has been reported |
| Common skin effects | Dryness, nail changes, sun sensitivity | Rash, itching, dry skin, occasional vitiligo-like patches |
| Usual onset | Often within 2–4 weeks of starting | Variable — can appear weeks to months into treatment, or not at all |
| Reversibility | Hair generally regrows after chemotherapy ends | Skin changes are usually manageable; rare patchy hair loss often improves over time |
Beyond hair
What Other Visible or Skin Changes Can Immunotherapy Cause?
Skin-related reactions are among the more common immune-related side effects of immunotherapy. Rash, itching and dry skin are the changes reported most often, and are usually manageable with guidance from your care team rather than a reason to stop treatment. Some patients being treated for melanoma develop small vitiligo-like patches where skin loses pigment — a change some studies have linked to a stronger treatment response, though it is not something to expect or hope for as a signal.
Nail changes are less common, and rare patchy hair loss resembling alopecia areata has also been described in the oncology dermatology literature, distinct from the diffuse thinning chemotherapy causes. None of these should be self-managed — any new skin, nail or hair change during immunotherapy is worth mentioning at your next review or sooner if it is spreading quickly or causing discomfort.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Want to Know Exactly What to Expect From Your Own Treatment?
A medical oncologist can walk through your specific regimen — hair, skin and every other side effect — free, confidential, and with no commitment to start treatment.
Understanding the mechanism
Why Does Immunotherapy Behave So Differently From Chemotherapy Here?
Chemotherapy drugs are designed to kill or slow down cells that divide quickly — a category cancer cells fall into, but so do hair follicle cells, the lining of the gut, and bone marrow cells. That shared vulnerability is why chemotherapy's side effects cluster around fast-growing tissue, hair included.
Checkpoint inhibitor immunotherapy does not work this way. Instead of acting on cell division, it removes the brakes cancer cells use to hide from the immune system, letting the body's own T-cells recognise and act against the tumour. Because this mechanism does not depend on how fast a cell divides, it does not routinely affect hair follicles — but it can, occasionally, cause the immune system to react against other normal tissue, including skin and, rarely, hair follicles themselves. That is a different kind of side effect (immune-related), not the mechanical one chemotherapy causes.
If a change does show up
If Hair or Skin Changes Do Appear, What Should You Do?
1
Note when it started and how it looks
Diffuse thinning across the scalp points toward a chemotherapy partner drug; small, well-defined patches point toward an immune-related reaction. Either detail helps your team assess it faster.
2
Mention it at your next review, or sooner if it's spreading
Most hair and skin changes on immunotherapy are manageable and do not require stopping treatment — but they should be assessed, not self-diagnosed from what you've read online.
3
Keep hair care gentle in the meantime
Mild shampoo, avoiding harsh chemical treatments, and protecting the scalp from strong sun are reasonable general precautions while any hair change is being assessed.
4
Give it time once treatment changes
If chemotherapy ends or a reaction settles with treatment, regrowth typically follows over the following weeks to months — your oncologist or a dermatology colleague can give a timeline specific to you.
You don't have to guess
Get Honest Answers on Every Side Effect, Not Just Hair
A medical oncologist can review your specific cancer type and regimen and tell you, plainly, what to expect — and what genuinely doesn't apply to you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Will I Lose My Hair on Immunotherapy? — Your Questions Answered
Does immunotherapy cause hair loss?
Checkpoint inhibitor immunotherapy, the type used at CION, does not commonly cause the diffuse hair loss associated with chemotherapy. Chemotherapy targets rapidly dividing cells throughout the body, including hair follicles, which is why hair thinning or loss is a well-known chemotherapy effect. Immunotherapy works differently — it helps the immune system recognise and act against cancer cells — and this mechanism does not typically damage hair follicles the same way. Most patients on immunotherapy alone keep their hair through treatment, though individual responses can vary and any new hair changes are worth mentioning to your care team.
Will I lose my hair if immunotherapy is combined with chemotherapy?
Possibly, yes — but the hair loss comes from the chemotherapy component of the combination, not from the immunotherapy itself. Many cancer treatment plans pair immunotherapy with chemotherapy, particularly for lung, breast and some other cancers, because the two work through different mechanisms and can be more effective together. If your regimen includes chemotherapy, expect the same hair-loss pattern chemotherapy usually causes; if immunotherapy is later continued on its own after chemotherapy ends, hair generally has the chance to grow back.
What other visible skin or hair changes can immunotherapy cause?
Skin-related reactions are among the more common immune-related side effects of immunotherapy, including rash, itching, and dry skin. Some patients, especially those being treated for melanoma, develop vitiligo-like patches where skin loses pigment in small areas — a change some studies have linked to a stronger treatment response, though it should never be treated as evidence you can rely on. Nail changes and, rarely, patchy hair loss resembling alopecia areata have also been reported. Any new skin or hair change during immunotherapy should be reported to your oncology team rather than managed on your own.
Can immunotherapy cause patchy hair loss like alopecia areata?
It can, though this is uncommon. Immunotherapy occasionally triggers immune-related reactions against hair follicles that resemble alopecia areata — patchy, well-defined areas of hair loss — rather than the diffuse thinning seen with chemotherapy. This is a recognised, if rare, immune-related adverse event described in oncology dermatology literature. It is generally manageable and is assessed by your care team alongside your other symptoms, rather than being a reason to stop immunotherapy on its own.
If my hair does thin during treatment, will it grow back?
In most cases, yes. Hair loss caused by a chemotherapy partner drug typically regrows once that chemotherapy course ends, following the same pattern seen after chemotherapy alone. Immune-related patchy hair loss linked to immunotherapy itself is usually manageable and often improves with time and, if needed, dermatology-guided care alongside your oncology team. Regrowth timing varies by individual, by the specific drugs used, and by how the hair loss occurred, so your oncologist and dermatologist are the right team to give you a timeline specific to your case.
Should I tell my care team about hair or skin changes during immunotherapy?
Yes, always. Even changes that seem minor — a new rash, patchy hair loss, or skin discolouration — can be an early sign of an immune-related side effect that your team will want to monitor or manage. Reporting changes early does not usually mean immunotherapy will be stopped; most skin and hair-related reactions are manageable without interrupting treatment. It does help your oncology team catch anything that needs closer attention before it becomes more serious.
This page is general patient-education information, not a substitute for the written guidance your own oncology team gives you based on your specific diagnosis, biomarker results and treatment plan.